#ViiV Healthcare

#2023USCHA was a Love Letter to Black Women—and a joyous family reunion for the HIV community. [VIDEOS]

The USPSTF’s latest recommendation could make long-acting PrEP (Apretude) more accessible—if a looming court case doesn’t interfere.

The 38th annual AIDS Walk New York supports GMHC and other HIV and AIDS groups. Plus: Don’t miss the Latex Ball!

This NWGHAAD, learn what all women need to know about HIV, including who is impacted most. Plus: Download self-care activity books.

Applications available March 1, 2023 for the next awards for the HIV/AIDS arts and social justice program

Daily pills and long-acting PrEP both scored a grade A for preventing HIV. Now Medicare is considering national coverage.

This special episode of the Fast-Track Cities podcast covers aging with HIV, measuring quality of life beyond viral suppression and more.

The U.S. Business Action to End HIV coalition boosts public-private partnerships and spells out six ways companies can fight the epidemic.

The ViiV Healthcare grants are a key element of the company’s Risk to Reason HIV initiative guided by and for Black women.

Held in Puerto Rico, #2022USCHA highlighted HIV in Latino populations, language justice, storytelling, music and much more.

Gilead, ViiV, NMAC, HRC, NBJC, GLAAD and others offer $5.5 million in grants to help community groups respond to monkeypox.

Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.

Cultural influencers promote HIV prevention.

Cultural influencers take off their blindfolds to destigmatize HIV prevention in ViiV’s “Me in You, You in Me” campaign. [VIDEOS]

Drugmaker Gilead Sciences led in private HIV/AIDS funding, reports FCAA, noting “a dangerous reliance on a shrinking pool of funders.”